177Lu-PSMA-617
Novartis
['prostate']
a feasibility study of 177lu-psma radioligand therapy alternated with radium-223 in pts w/ bone-metastatic, oligo-metastatic, #hspc after curative therapy: the #duet study. presented by . #asco23 coverage &gt; #prostatecancer 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology